AbCellera Biologics (ABCL) Institutional Ownership $1.99 -0.10 (-4.78%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$2.00 +0.01 (+0.25%) As of 06:08 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for AbCellera Biologics (NASDAQ:ABCL)CurrentInstitutional OwnershipPercentage61.42%Number ofInstitutional Buyers(last 12 months)66TotalInstitutional Inflows(last 12 months)$74.11MNumber ofInstitutional Sellers(last 12 months)34TotalInstitutional Outflows(last 12 months)$48.34M Get ABCL Insider Trade Alerts Want to know when executives and insiders are buying or selling AbCellera Biologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ABCL Institutional Buying and Selling by Quarter AbCellera Biologics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2025 UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC15,671,063$34.95M0.0%+248.2%5.251% 5/16/2025 Goldman Sachs Group Inc.86,483$193K0.0%-71.2%0.029% 5/15/2025 Royal Bank of Canada387,031$863K0.0%-4.9%0.130% 5/14/2025 EntryPoint Capital LLC187,822$419K0.2%+11.3%0.063% 5/13/2025 HighTower Advisors LLC21,486$48K0.0%-69.8%0.007% 5/12/2025 Virtu Financial LLC23,369$52K0.0%N/A0.008% 5/12/2025 Invesco Ltd.24,146$54K0.0%+114.6%0.008% 5/9/2025 JGP Global Gestao de Recursos Ltda.17,346$39K0.0%-23.2%0.006% 5/8/2025 XTX Topco Ltd45,253$101K0.0%-50.7%0.015% 5/8/2025 GSA Capital Partners LLP266,895$595K0.1%-54.7%0.089% Get the Latest News and Ratings for ABCL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AbCellera Biologics and its competitors with MarketBeat's FREE daily newsletter. 5/8/2025 Federated Hermes Inc.947,751$2.11M0.0%+3.4%0.318% 5/7/2025 Baillie Gifford & Co.11,195,832$24.97M0.0%-8.5%3.752% 5/6/2025 Pier 88 Investment Partners LLC243,790$544K0.1%+2.9%0.082% 5/5/2025 Allianz Asset Management GmbH25,622$60K0.0%+121.3%0.009% 5/2/2025 Signaturefd LLC16,447$37K0.0%-71.4%0.006% 4/30/2025 Moloney Securities Asset Management LLC14,400$32K0.0%-84.1%0.005% 4/30/2025 Stratos Wealth Advisors LLC12,000$27K0.0%N/A0.004% 4/23/2025 AssuredPartners Investment Advisors LLC15,356$34K0.0%N/A0.005% 4/22/2025 TrueMark Investments LLC115,391$257K0.1%-7.0%0.039% 4/17/2025 Janney Montgomery Scott LLC13,043$29K0.0%N/A0.004% 4/17/2025 GEM Asset Management LLC30,000$63K0.0%N/A0.010% 4/16/2025 Salem Investment Counselors Inc.78,800$176K0.0%+7.0%0.026% 2/18/2025Lantern Wealth Advisors LLC18,000$53K0.0%-22.7%0.006% 2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC4,500,000$13.19M0.0%-2.0%1.524% 2/17/2025 Squarepoint Ops LLC57,685$169K0.0%+333.1%0.020% 2/17/2025 Two Sigma Advisers LP2,608,400$7.64M0.0%+19.8%0.883% 2/17/2025 Two Sigma Investments LP3,257,311$9.54M0.0%+28.6%1.103% 2/17/2025 Tang Capital Management LLC2,582,816$7.57M0.5%+12.3%0.874% 2/17/2025 ProShare Advisors LLC13,990$41K0.0%-19.7%0.005% 2/17/2025 Prosight Management LP7,350,000$21.54M6.0%-19.0%2.488% 2/17/2025 Millennium Management LLC1,482,715$4.34M0.0%+96.7%0.502% 2/17/2025 Lazard Asset Management LLC928,594$2.72M0.0%-15.3%0.314% 2/17/2025 Graham Capital Management L.P.103,610$304K0.0%N/A0.035% 2/17/2025 Brevan Howard Capital Management LP83,519$245K0.0%+548.1%0.028% 2/17/2025 Balyasny Asset Management L.P.13,521$40K0.0%N/A0.005% 2/14/2025 Northern Trust Corp81,621$239K0.0%+106.9%0.028% 2/14/2025 Boothbay Fund Management LLC15,703$46K0.0%N/A0.005% 2/14/2025 Virtus ETF Advisers LLC24,099$71K0.0%-12.9%0.008% 2/14/2025 Stifel Financial Corp71,514$210K0.0%-4.4%0.024% 2/14/2025 Tower Research Capital LLC TRC12,210$36K0.0%-23.6%0.004% Trump’s treachery (Ad)I think Trump’s Treasury Secretary is destroying the stock market on purpose. And no one on Wall Street seems to understand why. Like an addict who needs desperate help, Trump’s Treasury pick, Scott Bessent, is putting America through a “detox period” — and I think it’s going to be absolutely brutal for our economy. Why’s he doing this?You may have already noticed the effect on your portfolio as markets have begun to bleed.2/14/2025 TD Waterhouse Canada Inc.104,594$306K0.0%-55.0%0.035% 2/14/2025 Capital World Investors7,933,613$23.25M0.0%N/A2.686% 2/13/2025 PEAK6 LLC199,995$586K0.0%N/A0.068% 2/13/2025 Walleye Capital LLC15,000$44K0.0%-94.2%0.005% 2/13/2025 XTX Topco Ltd91,754$269K0.0%N/A0.031% 2/13/2025 Mariner LLC14,540$42K0.0%N/A0.005% 2/13/2025 Barclays PLC38,351$112K0.0%+72.0%0.013% 2/13/2025 Raymond James Financial Inc.19,501$57K0.0%N/A0.007% 2/13/2025 Renaissance Technologies LLC2,486,893$7.29M0.0%-15.6%0.842% 2/13/2025 FIL Ltd24,061$70K0.0%-80.6%0.008% 2/13/2025 ADAR1 Capital Management LLC14,981$44K0.0%-87.0%0.005% 2/13/2025 Bank of Montreal Can51,447$151K0.0%-11.3%0.017% 2/13/2025 Federated Hermes Inc.916,237$2.69M0.0%-59.9%0.310% 2/13/2025 Quadrant Capital Group LLC54,709$160K0.0%+83.4%0.019% 2/13/2025 Envestnet Asset Management Inc.18,428$54K0.0%-20.6%0.006% 2/12/2025 RPO LLC20,937$61K0.1%N/A0.007% 2/12/2025 ExodusPoint Capital Management LP281,795$826K0.0%N/A0.095% 2/12/2025 DKM Wealth Management Inc.10,000$29K0.0%N/A0.003% 2/12/2025 Diametric Capital LP18,104$53K0.0%N/A0.006% 2/12/2025 Pier 88 Investment Partners LLC236,900$694K0.1%+21.2%0.080% 2/12/2025 DnB Asset Management AS305,579$895K0.0%+424.7%0.103% 2/12/2025 Norges Bank1,284,533$3.76M0.0%N/A0.435% 2/12/2025 JPMorgan Chase & Co.281,033$823K0.0%-21.0%0.095% 2/12/2025 TrueMark Investments LLC124,089$364K0.1%-7.7%0.042% 2/11/2025 EntryPoint Capital LLC168,682$494K0.2%+44.0%0.057% 2/11/2025 Guardian Partners Inc.1,786,414$5.41M0.6%N/A0.605% 2/11/2025 Commonwealth of Pennsylvania Public School Empls Retrmt SYS21,664$63K0.0%N/A0.007% 2/10/2025 Signaturefd LLC57,466$168K0.0%+61.2%0.019% 2/10/2025 IMG Wealth Management Inc.19,000$56K0.1%N/A0.006% 2/7/2025 HighTower Advisors LLC71,086$208K0.0%+577.9%0.024% 2/6/2025 Raymond James Financial Inc.19,501$57K0.0%N/A0.007% 1/31/2025Sanctuary Advisors LLC89,616$289K0.0%-5.8%0.030% 1/31/2025 State of New Jersey Common Pension Fund D12,232$36K0.0%N/A0.004% 1/31/2025 Baillie Gifford & Co.12,236,465$35.85M0.0%-5.1%4.143% 1/28/2025 Moloney Securities Asset Management LLC90,400$265K0.0%N/A0.031% 1/24/2025 China Universal Asset Management Co. Ltd.62,629$184K0.0%+10.5%0.021% 1/13/2025 Salem Investment Counselors Inc.73,650$216K0.0%-61.5%0.025% 1/13/2025 Green Alpha Advisors LLC37,835$111K0.1%-22.0%0.013% 12/26/2024 JPMorgan Chase & Co.355,747$925K0.0%+6.4%0.120% 12/13/2024B. Riley Wealth Advisors Inc.34,000$88K0.0%+58.1%0.012% 11/25/2024Sanctuary Advisors LLC95,116$263K0.0%-10.2%0.032% 11/16/2024 Geode Capital Management LLC113,653$295K0.0%-63.9%0.038% 11/15/2024 Stansberry Asset Management LLC83,937$218K0.0%-5.1%0.028% 11/15/2024 State Street Corp323,229$840K0.0%+1.5%0.109% 11/15/2024 Stifel Financial Corp74,814$195K0.0%-26.9%0.025% 11/15/2024 Quadrature Capital Ltd59,617$154K0.0%+328.0%0.020% 11/15/2024 Erste Asset Management GmbH62,000$162K0.0%N/A0.021% 11/14/2024 PDT Partners LLC64,304$167K0.0%-73.0%0.022% 11/14/2024 Walleye Capital LLC256,881$668K0.0%N/A0.087% 11/14/2024 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC4,590,103$11.93M0.0%-0.2%1.554% Washington Is Broke—and Eyeing Your Savings Next (Ad)Washington is running out of money…And guess where they'll look next? When governments go broke, they take from the people. It's happened before, and it's happening again. The Department of Justice just admitted that cash isn't legally YOUR property.Get your free guide now by clicking here >>11/7/2024 Clarkston Capital Partners LLC22,000$57K0.0%N/A0.007% 11/6/2024 Pier 88 Investment Partners LLC195,500$508K0.1%+21.0%0.066% 11/5/2024 Baillie Gifford & Co.12,894,703$33.53M0.0%-41.1%4.376% 11/5/2024 GSA Capital Partners LLP241,866$629K0.0%+991.3%0.082% 11/1/2024 Resolute Advisors LLC61,576$160K0.0%+7.0%0.021% 10/29/2024 Arcadia Investment Management Corp MI10,000$26K0.0%N/A0.003% 10/25/2024 China Universal Asset Management Co. Ltd.56,674$147K0.0%+64.1%0.019% 10/23/2024 Ballentine Partners LLC20,732$54K0.0%N/A0.007% 10/22/2024 Signaturefd LLC35,659$93K0.0%+244.0%0.012% 10/15/2024 NBC Securities Inc.11,420$29K0.0%+56.0%0.004% (Data available from 1/1/2016 forward) ABCL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ABCL shares? During the previous two years, 127 institutional investors and hedge funds held shares of AbCellera Biologics. The most heavily invested institutionals were Baker BROS. Advisors LP ($124.69M), UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC ($34.95M), Credit Suisse AG ($29.55M), ArrowMark Colorado Holdings LLC ($26.52M), Baillie Gifford & Co. ($24.97M), Capital World Investors ($23.25M), and Prosight Management LP ($21.54M).Learn more on ABCL's institutional investors. What percentage of AbCellera Biologics stock is owned by institutional investors? 61.42% of AbCellera Biologics stock is owned by institutional investors. Learn more on ABCL's institutional investor holdings. Which institutional investors have been buying AbCellera Biologics stock? Of the 104 institutional investors that purchased AbCellera Biologics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC ($11.17M), Capital World Investors ($7.93M), Baillie Gifford & Co. ($6.54M), Baker BROS. Advisors LP ($4.62M), ArrowMark Colorado Holdings LLC ($4.11M), Prosight Management LP ($1.80M), and Guardian Partners Inc. ($1.79M). How much institutional buying is happening at AbCellera Biologics? Institutional investors have bought a total of 47,784,293 shares in the last 24 months. This purchase volume represents approximately $189.62M in transactions. Which AbCellera Biologics major shareholders have been selling company stock? Of the 52 institutional investors that sold AbCellera Biologics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Baillie Gifford & Co. ($15.17M), Prosight Management LP ($1.73M), Federated Hermes Inc. ($1.71M), Lazard Asset Management LLC ($1.69M), Capital World Investors ($976.20K), Renaissance Technologies LLC ($734.71K), and Barclays PLC ($504.98K). How much institutional selling is happening at AbCellera Biologics? Institutional investors have sold a total of 26,034,496 shares in the last 24 months. This volume of shares sold represents approximately $91.55M in transactions. Related Companies HUTCHMED Institutional Ownership Amneal Pharmaceuticals Institutional Ownership Organon & Co. Institutional Ownership Mirum Pharmaceuticals Institutional Ownership Apellis Pharmaceuticals Institutional Ownership Denali Therapeutics Institutional Ownership Vericel Institutional Ownership Ascentage Pharma Group International Institutional Ownership NewAmsterdam Pharma Institutional Ownership Kymera Therapeutics Institutional Ownership This page (NASDAQ:ABCL) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbCellera Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbCellera Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
